393MO Evaluating medical oncology outcomes (EMOO) in Asia study: Molecular testing, treatment patterns and outcome of patients with stage IV non-squamous non-small cell lung cancer

R Stahel,L Mery,A Bardot,R Kanesvaran,T.C Keong,D Pongnikorn,N Prasongsook,S.H Hutajulu,C Irawan,A Ab Manan,M Thiagarajan,P Sripan,S Peters,H.H Storm,F Bray,R.A Soo

doi:10.1016/j.annonc.2022.10.360

393MO Evaluating medical oncology outcomes (EMOO) in Asia study: Molecular testing, treatment patterns and outcome of patients with stage IV non-squamous non-small cell lung cancer

R Stahel, L Mery + Show 14 more

Open Access

https://doi.org/10.1016/j.annonc.2022.10.360

Copy DOI

Journal: Annals of oncology : official journal of the European Society for Medical Oncology	Publication Date: Nov 1, 2022
License type: publisher-specific-oa

Affiliation: International Breast Cancer Study Group, International Agency For Research On Cancer, Universitas Gadjah Mada, National Cancer Institute, Hospital Kuala Lumpur, Maharaj Nakorn Chiang Mai Hospital, National University Cancer Institute, Singapore

#Non-squamous Non-small Cell Lung Cancer #International Agency For Research + Show 8 more

Abstract
Full-Text PDF
Similar Papers

Abstract

The EMOO in Asia Study established a clinical annotated population-based registry of lung cancer in a collaboration between ESMO, the International Agency for Research on Cancer, and partner institutions in Indonesia, Malaysia and Singapore and Thailand.

Full Text